Recent News

• 07.29.2026 - Integra LifeSciences Reports Second Quarter 2026 Financial Results
• 07.16.2026 - Integra LifeSciences to Host Second Quarter 2026 Financial Results Conference Call on July 29, 2026
• 07.02.2026 - Integra LifeSciences Appoints Topaz Kirlew Chief Regulatory Officer
• 06.23.2026 - Integra LifeSciences Announces Key Executive Appointments
• 06.15.2026 - Integra LifeSciences to Present at the 2026 Truist Securities MedTech Conference
• 06.02.2026 - Integra LifeSciences to Present at the 2026 Jefferies Global Healthcare Conference
• 05.08.2026 - Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference
• 05.05.2026 - Integra LifeSciences Announces Leadership Transition
• 05.05.2026 - Integra LifeSciences Reports First Quarter 2026 Financial Results
• 04.20.2026 - Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

Recent Filings

• 07.29.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 07.29.2026 - 8-K Current report
• 07.29.2026 - EX-99.1 EX-99.1
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 07.06.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 06.03.2026 - 4 Statement of changes in beneficial ownership of securities
• 05.29.2026 - SD Specialized disclosure report